Groove Botanicals Inc. (GRVE) intrinsic value & 10-year financials
Groove Botanicals Inc. (GRVE) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.00
- Market cap
- $298.2K
- Revenue (FY2026)
- —
- Revenue growth (10-yr CAGR)
- 37.8%
- ROIC (10-yr avg)
- 159.1%
- Free cash flow (FY2026)
- —
GRVE 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2026 | — | -$139.9K | -$0.01 | — | — | 10.9% |
| FY2025 | — | -$130.8K | -$0.01 | — | — | 14.0% |
| FY2024 | — | -$202.1K | -$0.01 | — | — | 33.7% |
| FY2023 | — | -$120.7K | $0.00 | — | — | 27.0% |
| FY2022 | — | — | — | — | — | — |
| FY2017 | — | -$243.2K | — | — | — | 35.6% |
| FY2016 | $428.1K | -$2.5M | — | — | -647.1% | -404.4% |
| FY2015 | $1.3M | $100.3K | — | — | -28.4% | -22.8% |
| FY2014 | $1.1M | -$786.0K | — | — | -57.1% | -49.4% |
| FY2013 | $163.6K | $30.0M | — | — | -351.2% | 1787.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
GROOVE BOTANICALS INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
GROOVE BOTANICALS INC. has historically struggled to out-earn its cost of capital, averaging just -4.6% ROIC.
GROOVE BOTANICALS INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, GROOVE BOTANICALS INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.33 per share.